Abstract
Sotalol is an effective antiarrhythmic drug for the maintenance of sinus rhythm in atrial fibrillation. However, its QTc-prolonging effect increases the risk for torsades de pointes (TdP) and sudden cardiac death. Thus, it is typically loaded in the inpatient setting with close cardiac monitoring
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
